42 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 May 24
InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
4:12pm
contributions, and leadership during her tenure with InMed and wish her all the best in her retirement. We congratulate her on a tremendous career in the biotech
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
from the date the Executive provided the Notice of Termination until the earlier of the date of resignation or retirement selected by the Executive
8-K
EX-99.1
9eqokx vpou
17 Nov 22
Departure of Directors or Certain Officers
4:10pm
424B3
9ftkq
19 Oct 22
Prospectus supplement
6:10am
8-K
EX-10.1
w76ib5adv
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
ofd ubh1a9
18 Mar 22
InMed Announces Management Changes
1:02pm
DEF 14A
fdepnfx1
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
1fd8zi7byodesr r4e
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
w35zjlszdy67rg6y4 vf
24 Sep 21
Annual report
7:31am
424B3
asvlna
22 Jul 21
Prospectus supplement
10:27am